Hospital Universitario Germans Trias i Pujol

Badalona, Catalonia 08916

0 studies enrolling now · 2 studies all time

What they study most

Advanced Cholangiocarcinoma, Chronic Lymphocytic Leukemia, FGFR2 Gene Mutation

Studies at this site

• Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations — Stopped early
• Study Evaluating the Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL) (Tugela ) — Completed